Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Dipen J. Parekh(University of Miami), Ian M. Thompson(The University of Texas at San Antonio Health Science Center), Vivek Venkatramani(University of Miami), Robert S. Svatek(The University of Texas at San Antonio Health Science Center), Alon Z. Weizer(University of Michigan), Edward Uchio(University of California, Irvine), Kerri Kendrick(The University of Texas at San Antonio Health Science Center), Alex Gorbonos(Loyola University Medical Center), Tracey L. Krupski(University of Virginia Cancer Center), Lynn Shemanski(Cancer Research And Biostatistics), Michael S. Cookson(University of Oklahoma Health Sciences Center), Marcus L. Quek(Loyola University Medical Center), Mathew Tollefson(WinnMed), Isildinha M. Reis(University of Miami), Badrinath R. Konety(Allina Health), Daniel A. Barocas(Vanderbilt University Medical Center), Gopal N. Gupta(Loyola University Medical Center), Michael Woods(University of Cambridge), Adam S. Kibel(Brigham and Women's Hospital), Raj S. Pruthi(University of North Carolina at Chapel Hill), Nachiketh Soodana‐Prakash(University of Miami), Christopher Weight, Joseph A. Smith(King's College London), Sam S. Chang(Vanderbilt University), David S. Sharp(The Ohio State University), Atreya Dash(University of Washington), Eila C. Skinner(Stanford University), Norm D. Smith(Caris Life Sciences (United States)), Erik P. Castle(WinnMed), Jeffrey S. Montgomery(Ann Arbor Center for Independent Living), Ahmad Shabsigh(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 779
Related Papers
The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
|New England Journal of Medicine|2003|2k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845